Pages that link to "Q39320214"
Jump to navigation
Jump to search
The following pages link to Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention. (Q39320214):
Displaying 15 items.
- Cellular Cholesterol Homeostasis in Alzheimer's Disease (Q39180626) (← links)
- β-Amyloid and the Pathomechanisms of Alzheimer's Disease: A Comprehensive View (Q47672665) (← links)
- The Cognitive Ageing, Nutrition and Neurogenesis (CANN) trial: Design and progress (Q58693317) (← links)
- Modulating Effect of Diet on Alzheimer's Disease (Q64232099) (← links)
- Development of a High Coverage Pseudotargeted Lipidomics Method Based on Ultra-High Performance Liquid Chromatography-Mass Spectrometry (Q88883368) (← links)
- Shared Causal Paths underlying Alzheimer's dementia and Type 2 Diabetes (Q90091568) (← links)
- Nutrients in the Prevention of Alzheimer's Disease (Q90355501) (← links)
- Low Phytanic Acid-Concentrated DHA Prevents Cognitive Deficit and Regulates Alzheimer Disease Mediators in an ApoE-/- Mice Experimental Model (Q90706367) (← links)
- Dementia in Down syndrome: unique insights for Alzheimer disease research (Q91410950) (← links)
- Cerebrospinal fluid lipidomics: effects of an intravenous triglyceride infusion and apoE status (Q91942413) (← links)
- Oligosaccharides from Morinda officinalis Slow the Progress of Aging Mice by Regulating the Key Microbiota-Metabolite Pairs (Q92591903) (← links)
- Circulating ceramide ratios and risk of vascular brain aging and dementia (Q92721755) (← links)
- Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials (Q93078497) (← links)
- Integrated Metabolomic and Lipidomic Analysis Reveals the Neuroprotective Mechanisms of Bushen Tiansui Formula in an Aβ1-42-Induced Rat Model of Alzheimer's Disease (Q97523876) (← links)
- 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease (Q99401468) (← links)